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spécifique histoplasmique à Histoplasma 
capsulatum var capsulatum
patiente de 55 ans originaire du village Yabaondo 
Province de la Tshopo. Son état général était 
satisfaisant excepté un amaigrissement et la 
présence de nombreux ganglions cervicaux 
gauches de taille variable, présumés tuberculeuses 
(TB). La biopsie a montré un remaniement de 
prolifération de gros macrophages bourrés des 
H. capsulatum var capsulatum. 
à H. capsulatum en RD Congo nous a motivé à 
de contribuer à la préparation de la lutte contre 
cette entité émergente/reémergente négligée. 
H. capsulatum var capsulatum 
doit être evoquée dans la demarche de diagnostic 
tropical.  
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Summary  
We have described herein the first lymphadenitis due to 
Histoplasma capsulatum var capsulatum with molecular 
characterization of the pathogen. The patient was a 55-year-
old female from a remote village of Yabaondo in the former 
Province Orientale, currently Tshopo Province, Democratic 
Republic of Congo (DRC) who presented with multiple 
swollen left neck lymph nodes. She reported weight loss 
(undefined) but was otherwise healthy, and a presumptive 
diagnosis of tuberculosis (TB) was postulated. The biopsy 
specimen yielded plenty yeast cells of H. capsulatum var 
capsulatum on Hematoxylin-Eosin routine staining. The 
molecular identity of the fungus was confirmed by 
immunohistochemistry at the Pasteur Institute of Paris. The 
rarity of reported cases of H. capsulatum var capsulatum in 
DRC prompted us to report this unique case to generate 
awareness and preparedness of this emerging/reemerging 
neglected tropical fungal infection against outbreaks. H. 
capsulatum var capsulatum needs to be considered in the 
work-up of lymphadenopathies in tropical environment.  
Keywords: Lymphadenitis, histoplasmosis, capsulatum, 
Yabaondo, DRC. 
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Introduction 
Although in Africa the classic Histoplasmosis 
capsulatum var capsulatum is believed to coexist with 
H. capsulatum var duboisii, only one non-HIV pediatric 
case has been recorded in the recent literature from DR 
Congo in 1982 at the General Referral Hospital of 
Kinshasa (formerly Mama Yemo General Hospital) 
compared to the commonest H. duboisii or African 
Histoplasmosis clade. Authors report the first adult case 
of lymphadenitis due to H. capsulatum var capsulatum 
and hope to generate awareness and preparedness on 
this neglected tropical fungal infection. 
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Methods 
A lymph node specimen fixed in 10% formalin 
was accessioned and archived in our laboratory 
at the Department of Pathology, Kinshasa 
University Hospital. The biopsy was processed 
per standard technics for histopathology and 
stained with Hematoxylin and Eosin (HE). The 
diagnosis of H. capsulatum was made. Recently, 
we retrieved the block and performed additional 
Periodic Acid-Schiff (PAS), Grocott 
Methenamine Silver (GMS) special staining as 
well as ancillary immunohistochemistry (IHC) 
using an anti H. capsulatum var capsulatum 
monoclonal antibody developed at the Pasteur 
Institute, Paris. 
Case report 
The patient was a 55-year-old female from a 
remote rural area of Yabaondo rural hospital 
(Tshopo province, formerly a district of Oriental 
Province, map figure 1).  
 
 
Figure1. Location of Yabaondo in Province of 
Tshopo (capital: Kisangani), Isangi District. 
Democratic Republic of Congo 
She presented with multiple swollen left neck 
lymph nodes filled with purulent material 
clinically presumed for tuberculosis (TB). She 
reported weight loss but was otherwise healthy. 
No other pertinent symptoms like fever, pain, 
vomiting, cough, pulmonary disease were 
recorded. Pus culture was reported negative. 
Initial microscopic examination of the specimen 
revealed an encapsulated lymph node 
parenchyma (Figure 2a). The normal follicular 
pattern has been completely replaced by a 
proliferation of numerous large macrophages 
filled with plenty of small rounded to ovoid 
encapsulated yeasts consistent with H. 
capsulatum var capsulatum (Hcc) (Figure 2b) 
with areas of homogenous caseating-like 
necrosis (Figure 2c). 
 
Figure 2. Photomicrographs of H. capsulatum 
lymphadenitis: (a) Low magnification of an 
encapsulated lymph node showing homogenous 
pattern with effacement of normal follicular 
architecture (HE); (b) macrophages filled with tear-
drop shaped encapsulated yeasts of Hcc (HEx25) (c) 
area of eosinophilic necrosis (arrow) (HE x10) 
 
Recently, the paraffine block was retrieved and 
brought to France for reevaluation and additional 
histochemical staining with HE, periodic Schiff 
acid (PAS), Grocott methenamine silver (GMS) 
or Gomori-Grocott (Fig.3a) and Fontana Masson 
at Pasteur Institute of Paris. The results 
confirmed the fungus Hcc, while 
immunohistochemistry (IHC, Figure 3b, c) 
yielded strong positivity to Hcc. The 
microorganisms measured roughly 4 m in 
diameter consistent with Hcc. These whole 
results were validated by the molecular 




Figure 3. Photomicrographs of ancillary technics. 
Plenty intracellular yeast microorganisms (a) within 
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macrophages (Grocott-Gomori), (b) in multinucleate 
giant cells (arrow) and (c) in macrophages, with 
dense core positive staining. (IHC, PAP stain) 
 
Discussion 
We have reported the first lymphadenitis due to 
Hcc from the DRC. The etiologic fungus 
molecular phenotype was confirmed by an IHC 
assay. Histoplasmosis is a disease caused by an 
infection by a fungus known as H. capsulatum, a 
thermally dependent dimorphic fungus which is 
common in the environment, most frequently in 
association with bird or bat droppings. The 
fungus takes a mycelial form at room 
temperature and transforms to a yeast form in 
host tissue or at 35°-38°C in certain culture 
media. Some people also refer to the disease as 
disease, classic 
histoplasmosis, or mainly as North American 
histoplasmosis (1-2). Phylogenetic studies of H. 
capsulatum have identified at least eight clades, 
which correspond to different geographic 
regions. The African clade includes those 
isolates previously classed as H. capsulatum var. 
duboisii (Hcd) due to H duboisii as well as those 
classed as H. capsulatum var. capsulatum due to 
Hcc and H. capsulatum var. farciminosum (3). 
Histoplasmosis has predominantly a rural or 
village distribution and its occurrence is related 
to exposure to soils enriched by the fecal 
Indeed, Histoplasma has been isolated from soil 
of chicken houses, caves, hollow trees and 
barnyard considered therefore as reservoirs of 
infection (1-2). Infection occurs after inhalation 
of conidia from the dust generated when soil is 
disturbed. The clinical presentation of 
histoplasmosis is highly dependent on two major 
factors  the size of the inoculum, and the 
immune status of the host. In some respects, the 
relationship between histoplasmosis infection 
and immune competence is analogous to primary 
TB; infants, elderly and immune compromised 
patients are likely to develop a (rapidly) 
progressive pulmonary and systemic infection 
that is often fatal, but in most immune competent 
adults, the primary infection is self-limited, and 
indeed is often not diagnosed in endemic 
regions. All age-groups are affected with a 
maximum incidence in the second decade (1-2). 
Males are more affected than females. Hcc is a 
disease of the mononuclear phagocytic system 
(MPS) previously known as the 
reticuloendothelial system. When aerosolized 
spores reach the respiratory tract, they are 
phagocytosed by alveolar macrophages; after 
development of intracellular yeast forms and 
reproduction by budding, hematogenous 
dissemination can lead to the involvement of 
lymph nodes and other organs followed by 
occurrence of foci of granulomatous 
inflammation (4). In 1982, a single pediatric case 
of Hcc was reported in Kinshasa. The 4-year-old 
immunocompetent girl originated from the rainy 
forest village Bokote (former Equator province) 
and had a generalized disease (5). The patient 
under consideration in this study was an adult 
female with unknown HIV status although the 
patient was seen before the HIV/AIDS pandemic 
era (1976). Her disease was limited to the neck 
lymph nodes and was probably misdiagnosed 
and mishandled as TB. It is likely that she 
acquired the disease through her daily chores in 
the woods or farming. There is no existing 
knowledge about Hcc in Yabaondo. Recent 
personal telephone interviews among former 
and/or current physicians having worked in 
Yabaondo yielded complete lack of knowledge 
about this pathology. The initial clinical 
assumption was TB, like in most cases of 
lymphadenopathies in this country with purulent 
material mimicking caseous necrosis. No further 
case of Hcc was found in the files of the 
Department of pathology up to now. Recent 
studies from Southern America revealed that 
implementation of a training course increased 
the diagnosis of Hcc in Colombia (6). It is likely 
that implementing similar training courses could 
enhance recognition of Hcc in several parts of 
DR Congo as part of preparedness against severe 
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epidemics that may occur like in several parts in 
world. Remarkably, the most encountered 
Histoplasma clade in DRC remains the H. 
capsulatum var. duboisii (7-8). Histopathology 
remains the gold standard for the diagnosis of 
the fungus. Morphologic defining features of the 
etiologic microorganism remain the size of the 
yeasts (1-3 µm vs 7-15 µm for Hcd) and the 
MPS exclusive composition of the 
granulomatous inflammatory infiltrate. The 
Infectious Diseases Society of America has 
developed guidelines for the treatment of 
histoplasmosis using Ketoconazole or 
ItraconazoleR (9). Hcc is the most common cause 
of fungal respiratory infection globally. While 
most infections are mild, 10% of cases can be 
life-threatening such as inflammation of the 
pericardium and fibrosis of major blood vessels 
(10). 
Conclusion 
To the best of our knowledge, this is the first 
case of lymphadenitis due to Hcc in DRC with 
ancillary molecular identification of the fungus. 
Generating the awareness is incredibly important 
because the condition is nowadays largely 
unknown, misdiagnosed, and mishandled. 
Finally, Hcc should be considered in the workup 
of most lymphadenopathies in tropical 
environment.  
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